Abstract
Cardiovascular diseases (CVDs) continue to be one of the leading causes of death on a global scale.Medications from the statin class are widely used in medical practice due to their action on systemic cholesterol. However, their frequent use in clinical practice and research studies has been strongly associated with recurring cases of statin-associated muscle symptoms (SAMS), ranging from…